Background: Genomewide association studies have shown a relation between plasma vitamin B-12 concentration and the 461G/A polymorphism of fucosyltransferase 2 (FUT2), a gene associated with susceptibility to Helicobacter pylori infection. Objective: We evaluated in 2 populations the association of FUT2 461 G/A polymorphism with vitamin B-12 and related metabolic markers and investigated whether the influence of FUT2 on H. pylori serology is part of the mechanisms that underlie these associations. Design: The study included 1282 ambulatory subjects from Europe and West Africa. Blood concentrations of vitamin B-12, folate, homocysteine, and methylmalonic acid were measured. Genotyping was performed by real-time polymerase chain reaction. H. pylori serology testing was performed by using ELISA. Results: In univariate analysis, FUT2 461 A/A genotype was associated with higher plasma vitamin B-12 concentration in the total population (P = 0.0007) as well as in Europe (P = 0.0009) and in West Africa (P = 0.0015). Positivity for H. pylori serology was higher in West Africa (P , 0.0001) and was not associated with low plasma vitamin B-12. The prevalence of H. pylori-positive patients did not differ among FUT2 461 G/A genotypes (P = 0.2068). In multivariate analysis, FUT2 461 G/A genotype (P = 0.0008), but not positive H. pylori serology, was an independent predictor of plasma vitamin B-12 concentration. Conclusion: This study confirms the influence of FUT2 461 G/A polymorphism on plasma vitamin B-12 concentration and showed no influence of H. pylori serologic status on this association in ambulatory subjects from Europe and West Africa.
INTRODUCTION
Vitamin B-12 (cobalamin) is a water-soluble vitamin that is required in one-carbon metabolism (1) . Cobalamin is found in animal foods, meat, milk, egg, fish, and shellfish (2) . Uptake of dietary vitamin B-12 and its delivery to cells is a complex process, requiring 3 cobalamin-binding proteins-intrinsic factor, haptocorrin (previously known as R-binder), and transcobalamin-and their cell membrane receptors (1) . Vitamin B-12 is a cofactor required for the remethylation of homocysteine to methionine by methionine synthase and is part of one-carbon metabolism, which is essential for purine and thymidylate synthesis, which is necessary for maintenance of genomic integrity (3). Data from genomewide association studies suggested that plasma vitamin B-12 concentration could be influenced by genetic polymorphisms (4-6). Hazra et al (4) showed that white women who were homozygous for fucosyltransferase 2 (FUT2) rs492602 G (NG_007511.1, located on chromosome 19 at 19q13.3.), which is in strong linkage disequilibrium with the FUT2 rs601338 [461 G/A (NM_000511) according to the Human Genome Variation Society, also known as 428 G/A] nonsecretor variant allele (W143X variant), had higher plasma vitamin B-12 concentrations.
It has been suggested that the association between FUT2 and low plasma vitamin B-12 concentration may be the consequence of susceptibility to Helicobacter pylori infection in carriers of the FUT2 secretor status as compared with individuals with the nonsecretor status (5) . However, no study to date has evaluated the relation between FUT2 polymorphism and H. pylori serologic status. Furthermore, data regarding the influence of FUT2 polymorphism on the overall profile of one-carbon metabolism markers are lacking, and no study has evaluated in multivariate analysis the influence of FUT2 polymorphism on vitamin B-12 concentration.
The aims of the study were as follows: 1) to appraise the distribution of FUT2 461 G/A (rs601338) polymorphism and to assess its influence on one-carbon metabolism markers (vitamin B-12, folate, homocysteine, and methylmalonic acid) and 2) to investigate the potential association between H. pylori infection and FUT2 461 G/A polymorphism in the general population.
SUBJECTS AND METHODS

Study populations
Between January 1999 and December 2006, ambulatory subjects were included from 3 countries: Italy [OASI cohort, Sicily (7)], Benin (coastal urban area of Cotonou), and Togo (the coast, Lomé, and the Savanna). These populations have been previously reported on in 2 studies (8, 9) . Italian subjects were considered representative of the European continent, and those from Benin and Togo were considered representative of the West African region. Institutional review board approval was obtained from the ethical committees of the Medical Centre of Troina (Instituto di Ricovero e Cura a Carattere Scientifico, the Oasi Maria Institute, Institute for Research on Mental Retardation, Troina, Sicily, Italy), the University Hospital of Nancy (Vandoeuvrelès-Nancy, France), the University of Benin (Cotonou, Benin), and the University of Lomé (Lomé, Togo) (8) (9) (10) . Written informed consent was obtained from participants. All participants had received a systematic clinical evaluation to rule out cancer, cardiovascular, renal, hepatic, or genetic disease and any vitamin supplementation before inclusion in the study.
Blood sampling
Phlebotomy was performed, and fasting venous blood was collected in EDTA-containing tubes. Samples were centrifuged immediately at 2500 g for 15 min at room temperature. Aliquots were stored at 270°C until analysis.
Vitamin B-12, folate, homocysteine, and methylmalonic acid assays All specimens were tested in a single laboratory (Vandoeuvrelès-Nancy, France). Homocysteine and methylmalonic acid were determined by ultra-performance liquid chromatography-tandem mass spectrometry procedure as previously published (11) , with an Acquity ultra-performance liquid chromatography bridged ethylsiloxane/silica hybrid (UPLC BEH) C18 column (1.7 lm, 2.1 · 50 mm; Waters Corporation). Methylmalonic acid was assessed only in the European population. Plasma vitamin B-12 and folate concentrations were assayed with a vitamin B-12 and folate immunoassay kit by means of automated chemiluminescence (ASC:180 Automated Chemiluminescence Systems; Chiron Diagnostics). The intraassay CVs for vitamin B-12, folate, homocysteine, and methylmalonate were 2.8%, 5.1%, 4.5%, and 7.3%, respectively.
H. pylori testing
Serum specimens were tested for the presence of IgG antibodies against H. pylori by using ELISA (Mastazyme Helicobacter; Mast Diagnostic) according to the manufacturer's instructions. Classification of infection status followed the manufacturer's instructions.
Analysis of genomic DNA
Genomic DNA was isolated from peripheral leukocytes by using a Qiagen kit (Qiagen-France). Fluorescence resonance energy transfer real-time polymerase chain reaction (PCR) was performed for the genotyping of FUT2 461 G/A (rs601338) polymorphism by using a LightCycler 480 instrument (Roche Molecular Biochemicals). The 5# to 3# DNA sequences of forward primer, reverse primer, sensor probe, and anchor probe used for the FUT2 461 G/A polymorphism were AGATT-CAAGCCATGTGGGAGTTA, CTTCCACACTTTTGGCATGAC, CCTGCTCCTACACCTTCTACC, and CCACCTCCGCCAGGA-GATCCTC, respectively. PCR was performed in a 96-well plate in a total volume of 10 lL. The final reaction contained 10 ng genomic DNA, 0.5 lmol/L each of forward and reverse primers, 0.2 lmol/L each of the sensor and anchor probes (TIB MOL-BIOL Syntheselabor GmbH), and 2 lL of LightCyclerÒ 480 Genotyping Master kit (kit for 384 reactions). Real-time PCR for FUT2 461 G/A (rs601338) genotyping was performed by an initial denaturation at 95°C for 10 min, followed by 45 cycles of 95°C for 10 s, 59°C for 10 s, and 72°C for 20 s. To determine the melting points after the amplification phase, a melting curve analysis was performed at 95°C for 20 s and at 40°C for 20 s, followed by slow heating at the rate of 0.2°C/s until reaching 85°C.
Statistical analysis
All quantitative variables are described as medians and percentiles (IQR, 25th-75th percentile). All proportions and genotype frequencies are expressed as percentages with 95% CIs. Genotype distributions were tested for consistency with expected Hardy-Weinberg equilibrium proportions, including analysis for ascertainment bias, according to the method proposed by Rodriguez et al (12) . Proportions were compared by using the chi-square test or Fisher's exact test, as appropriate. All correlations were studied by using Spearman's rank-order correlation coefficient. The comparison of plasma concentrations of vitamin B-12 (pmol/L), folate (nmol/L), homocysteine (lmol/L), and methylmalonic acid (lmol/L) between FUT2 461 G/A genotypes, was performed by using the Kruskal-Wallis test; post hoc analysis for pairwise comparison of subgroups was performed according to Conover, to avoid multiple testing problems (13) . To evaluate the influence of baseline characteristics and FUT2 461 G/A polymorphism on plasma concentrations of vitamin B-12 (pmol/L), folate (nmol/L), homocysteine (lmol/L), and methylmalonic acid (lmol/L), univariate analyses were carried out by using Spearman's rank-order correlation coefficient, the Mann-Whitney U test, or the Kruskal-Wallis test, as appropriate. All significant items obtained in univariate analyses were integrated into a multiple regression model for multivariate analysis by using a stepwise method. All variables with a P value ,0.1 were included in the model, and the variables with P values ,0.05 were retained in the model. Correction for multiple comparisons was performed by using the Bonferroni test. All of the reported P values were 2-sided, and P values ,0.05 were considered significant. Statistical analyses were performed by using MedCalc software, version 11.4.4 (MedCalc Software).
RESULTS
Baseline characteristics
A total of 1282 ambulatory participants were included in the study (Italy, n = 657; West Africa, n = 625: Benin, n = 517; Togo, n = 108). The median age of the study population at inclusion was 60 y, and the median plasma concentrations of vitamin B-12 and folate were within the reference values ( Table  1) than in European subjects (92.1% compared with 81.0% for West Africa and Europe, respectively; P , 0.0001) ( Table 1) .
Influence of H. pylori serologic status on one-carbon metabolism markers in European and West African populations
Total population
In the total population, H. pylori-positive serology was not associated with a lower vitamin B-12 concentration. Conversely, plasma folate concentration was significantly higher in H. pylori-negative subjects (11.4 nmol/L; IQR: 8.5-15.9 nmol/L) than in H. pylori-positive subjects (9.8 nmol/L; IQR: 6.7-13.9 nmol/L) (P , 0.0001) ( Table 2 ).
Europe
In Europe, H. pylori-positive subjects had significantly lower plasma folate (P = 0.03) and methylmalonate concentrations (P = 0.0008) than did H. pylori-negative subjects. Plasma concentrations of vitamin B-12 and homocysteine did not differ according to H. pylori serologic status (Table 2) .
West Africa
In the West African population, H. pylori serologic status did not influence the plasma concentrations of vitamin B-12, folate, homocysteine, and methylmalonic acid ( Table 2 ).
FUT2 461 G/A genotype frequency distribution
The distribution of FUT2 461 G/A genotype frequencies in European and West African populations is reported in Table 3 . This distribution of FUT2 461 G/A genotype is consistent with the Hardy-Weinberg equilibrium model (see Supplemental Table  1 under "Supplemental data" in the online issue). The homozygous FUT2 wild-type genotype (G/G) was more prevalent in West Africa than in Europe (36.0% compared with 21.2%, P , 0.0001). Conversely, the heterozygous genotype (FUT2 461 G/A) was more frequent in Europe than in West Africa (52.0% compared with 42.7% for Europe and West Africa, respectively; P = 0.001) ( Table 3 ). The proportion of the FUT2 nonsecretor genotype (A/A) did not differ between European and West African participants (26.8% compared with 21.2% for Europe and West Africa, respectively; P = 0.0502) ( Table 3 ). It should be noted that the prevalence of the FUT2 secretor phenotypecorresponding to FUT2 461 G/G or G/A genotypes-did not differ between European (73.2%) and West African (78.8%) populations (P = 0.0502) ( Table 3) .
Influence of FUT2 461 G/A polymorphism on H. pylori serologic status in European and West African populations
The prevalence of positive H. pylori serology did not differ across FUT2 461 G/A genotypes in the total population or in Europe and West Africa (P = 0.2068, P = 0.4712, and P = 0.8785, respectively) ( Table 4) . Consistently, the prevalence of positive H. pylori serology did not differ between FUT2 secretor and FUT2 nonsecretor groups in the total population (P = 0.18) or in Europe (P = 0.27) and West Africa (P = 0.80) ( Table 4) . 
Influence of FUT2 461 G/A polymorphism on one-carbon metabolism markers in European and West African populations
In the total population, vitamin B-12 concentration was influenced by FUT2 461 G/A polymorphism, with median concentrations of 310, 325, and 378 pmol/L in subjects with FUT2 461 G/G, G/A, and A/A genotypes, respectively (P = 0.0007) ( Table 5 ). The effect of FUT2 461 G/A polymorphism on the concentration of vitamin B-12 was consistently observed in both European (P = 0.0009) and West African (P = 0.0015) populations (Table 5) . In H. pylori-positive participants, plasma vitamin B-12 concentration was significantly influenced by FUT2 461 G/A polymorphism in the total population (P = 0.0016) (see Supplemental Table 2 under "Supplemental data" in the online issue). In the H. pylori-negative group, the limited sample size allowed the evaluation of this association only in the European subjects. In this H. pylori-negative European subgroup, there was an influence of FUT2 461 G and A alleles on plasma vitamin B-12 concentration, with vitamin B-12 concentrations of 247.8 pmol/L (IQR: 181.8-299.0 pmol/L) and 323.5 pmol/L (IQR: 196.9-423.6 pmol/L) for G/G and A/A homozygous genotypes, respectively (P = 0.0063). Plasma folate concentration was significantly associated with FUT2 461 G/A polymorphism in the total population but not in European (P = 0.14) and West African (P = 0.10) populations (Table 5) . Plasma homocysteine concentration was significantly associated with FUT2 461 G/A polymorphism in West Africa (P = 0.02) but not in Europe (P = 0.21) ( Table 5 ). Plasma methylmalonic acid concentration was not influenced by FUT2 461 G/A polymorphisms in the European population (Table 5) .
FUT2 secretor phenotype influenced only vitamin B-12 concentrations, with significantly higher vitamin B-12 concentrations in the FUT2 nonsecretor group than in the FUT2 secretor group in the total population (P = 0.0004) as well as in Europe (P = 0.0005) and West Africa (P = 0.0092) (see Supplemental  Table 3 under "Supplemental data" in the online issue). 
Independent predictors in multivariate analysis of vitamin B-12 concentration in European and West African populations
In multiple regression analysis, FUT2 461 G/G genotype was negatively and independently associated with plasma vitamin B-12 concentration in the total population (b coefficient = 257.64; SE: 17.19; P = 0.0008) ( Table 6 ). Consistently, when the "FUT2 461 G/G or G/A genotype" item-which corresponds to FUT2 secretor phenotype-was considered in the regression model, it was independently and negatively associated with vitamin B-12 concentration in the total population (b coefficient = 257.89; SE: 17.13; P = 0.0008) (Supplemental Table 4 under "Supplemental data" in the online issue). Male sex was negatively and independently associated with plasma vitamin B-12 (Table 6 ). Conversely, the West African geographic area was positively and independently associated with plasma vitamin B-12 concentration (Table 6 and Supplemental Table 4 under "Supplemental data" in the online issue). Positive H. pylori serology was not an independent predictor of plasma vitamin B-12 concentration (Table 6 and Supplemental Table 4 under "Supplemental data" in the online issue). No interaction was found between FUT2 461 G/A polymorphism and H. pylori serologic status.
DISCUSSION
This study, which was performed in a general population setting encompassing West African and European ambulatory subjects, showed that FUT2 461 G/A polymorphism was an independent predictor of plasma vitamin B-12 concentration. These results are consistent with the data from 2 genomewide association studies conducted in white populations (5, 6) . The family of a-1,2-fucosyltransferases (also known as the Se enzyme) catalyzes the addition of fucose-a hexose deoxy sugarin a-1,2 linkage to the galactose of types 1 and 2 disaccharide to form H type 1 and H type 2 antigens, respectively (14) . The FUT2 variant is a physiologic trait that regulates the expression and secretion of ABH blood group antigens in epithelial cells of glands (15) . Approximately 20% of whites are nonsecretors who do not express ABO blood group antigens in saliva because they are homozygous for the FUT2 461 null allele (A/A) (15) . In Europeans, Africans, and Iranians, the FUT2 nonsecretor genotype variant was associated with higher vitamin B-12 concentrations than in carriers of the secretor genotype (5, 15).
Hazra et al (4) showed that white women who were homozygous for the G allele of rs492602, which is in strong linkage disequilibrium with rs601338, had higher vitamin B-12 concentrations. Here, we performed the direct genotyping of rs601338 and showed its association with plasma vitamin B-12 concentration among 1282 adult subjects from Europe and West Africa. Although the difference in H. pylori prevalence between European and West African populations was statistically significant, it was not dissimilar enough to be clinically relevant. It has been suggested that the reduced vitamin B-12 concentration in carriers of the FUT2 secretor phenotype is a consequence of increased susceptibility to H. pylori infection (5). Indeed, FUT2-null mice displayed an altered glycosylation profile and impaired BabA-mediated H. pylori adhesion to gastric mucosa (16) . In a prospective study in 304 H. pylori-infected individuals, Azevedo et al (17) showed that FUT2 secretor phenotype was associated with H. pylori infection and with severity of H. pylori-induced gastric lesions. During the gastric phase of vitamin B-12 absorption, the low pH of the stomach and the peptic acid digestion of food proteinbound cobalamin are necessary for the release of cobalamin (18) (19) (20) . H. pylori-induced chronic atrophic gastritis may cause a disturbance of acid/peptic secretion, which can in turn cause food-cobalamin malabsorption (20, 21) . This was suggested by a Finnish population-based study that reported a high prevalence of H. pylori infection among subjects with chronic atrophic gastritis and low vitamin B-12 status (22) . By contrast, in a casecontrol study, Stettin et al (23) evaluated one-carbon metabolism markers in 90 healthy subjects, of whom 69 had positive H. pylori serology, and did not find any significant impact of H. pylori-positive serology on vitamin B status. Consistent with Stettin et al (23) , vitamin B-12 concentration was not influenced by H. pylori serology in our study of ambulatory subjects with no reported digestive disorder. This can be explained by the fact that H. pylori-positive serologic status does not necessarily imply the presence of chronic atrophic gastritis. In a large, prospective, population-based cohort from Germany, among H. pylori-positive subjects only 2.7% developed chronic atrophic gastritis after 5 y of follow-up (24) . Moreover, in a prospective study in 202 subjects, most H. pylori-positive subjects had normal egg yolk-cobalamin absorption test results (20) .
In our study, H. pylori-positive subjects had lower plasma folate concentrations. This result is in agreement with a previous report (25) , suggesting a role of H. pylori-related gastritis in modulating folate status. In our study, male sex was negatively and independently associated with plasma vitamin B-12 concentration. These results are in line with a previous study that reported a higher frequency of mild cobalamin deficiency in elderly white men in comparison with black and Asian American women (26) .
To our knowledge, our study is the first that has examined the influence of FUT2 polymorphism on H. pylori serologic status. Note that FUT2 461 G/A polymorphism as well as FUT2 secretor phenotype were not predictive of H. pylori positive serology. In addition, FUT2 461 G/G genotype was an independent predictor of vitamin B-12 concentration. It may be assumed that subjects with negative H. pylori serology had no reactive contact with H. pylori. Accordingly, a part of the influence of FUT2 polymorphism on vitamin B-12 concentration was independent from H. pylori-related mechanisms. Hence, an alternative hypothesis could be that the reduced vitamin B-12 concentration in carriers of the FUT2 secretor phenotype results in part from an influence of FUT2 on other mechanisms related with either absorption or transport of vitamin B-12. This needs to be investigated further in experimental models.
It should be noted that, similar to our study, the study by Hazra et al (4) showed that vitamin B-12 concentration remained within the normal range in each of the 3 genotypes of the FUT2 rs601338 polymorphism. Hence, even though the FUT2 polymorphism is involved in the variation of vitamin B-12 concentration, it is not by itself a predictor of vitamin B-12 deficiency. In our study, FUT2 polymorphism consistently showed no effect on methylmalonate concentration in the 2 populations; it had a very weak effect on homocysteine concentration in West African participants, and no effect in Europeans. Our results confirm those from 2 previous studies that found no influence of FUT2 polymorphism on plasma homocysteine concentration (5, 6) . The higher concentration of vitamin B-12 observed in West African subjects, compared with Europeans, was presumably not related to environmental exposure, because this difference was previously observed between whites and Africans living in the United Kingdom (27) . In line with our findings, a study in 30 Nigerians and 10 Europeans living in northern Nigeria found higher vitamin B-12 plasma concentrations in Nigerians than in Europeans (28) . Interestingly, the plasma concentration of transcobalamin II was higher in Nigerian subjects than in Europeans subjects living in Nigeria (28) . The reasons for this difference in the concentrations of vitamin B-12 have not been fully elucidated and might be related to genetic factors (29) . Among these, FUT2 would have had a limited influence to explain this higher concentration of vitamin B-12, because the frequency of FUT2 nonsecretor phenotype (FUT2 461, A/A genotype) was not significantly different in the 2 populations. Furthermore, H. pylori serologic status was not a contributing factor to this difference between Africans and Europeans, because it was not a predictor of vitamin B-12 concentration in either population.
In conclusion, this is the first study performed in a general population setting that evaluated the influence of H. pylori serologic status on the association between FUT2 461 G/A polymorphism and vitamin B-12 concentration. We found that H. pylori serologic status had no influence on this association. This suggests the involvement of another mechanism of FUT2 in its influence on vitamin B-12 concentration, in addition to its possible effect on H. pylori gastritis, at least in ambulatory subjects from Europe and West Africa.
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